Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

florida pharmaceutical products, llc - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine hydrochloride extended-release capsules is indicated in adults for the treatment of: - major depressive disorder (mdd) [see clinical studies (14.1)] - generalized anxiety disorder (gad) [see clinical studies (14.2)] - social anxiety disorder (sad) [see clinical studies (14.3)] - anic disorder (pd) [see clinical studies (14.4)] venlafaxine hydrochloride extended-release capsules is contraindicated in patients: - with known hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate or to any excipients in the formulation [see adverse reactions (6.2)] . - taking, or within 14 days of stopping, maois (including the maois linezolid and intravenous - methylene blue) because of the risk of serotonin syndrome [see dosage and administration (2.11), warnings and precautions (5.2), and drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants, including venlafaxine hydrochloride extended-rele

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administered drugs where compatibility has been established.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administered drugs where compatibility has been established.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 30 g/l - injection, solution - excipient ingredients: water for injections - indications as at 9 october 2002: hypertonic sodium chloride (3%) is used in the management of severe sodium chloride depletion when electrolyte restoration is required.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - indications as at 9 october 2002: sodium chloride (0.9%) intravenous infusion is indicated for extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - indications as at 9 october 2002: hypotonic sodium chloride (0.45%) is mainly used as a hydrating agent solution.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

solco healthcare llc - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 10 mg - fosinopril sodium tablets are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see dosage and administration ). in using fosinopril sodium, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril sodium does not have a similar risk (see warnings ). in considering use of fosinopril sodium, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients

Združene države Amerike - angleščina - NLM (National Library of Medicine)

eon labs, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 10 mg - fosinopril sodium tablets are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see dosage and administration ). in using fosinopril sodium tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril sodium tablets do not have a similar risk (see warnings ). in considering use of fosinopril sodium tablets, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride 9 mg in 1 ml